Fairfield, CA, United States of America

Evan N Feinberg

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Fairfield, CA (US) (2022)
  • Palo Alto, CA (US) (2019 - 2023)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Evan N Feinberg

Introduction

Evan N Feinberg is a prominent inventor based in Fairfield, CA (US), known for his significant contributions to the fields of drug discovery and molecular simulation. With a total of 5 patents, Feinberg has developed innovative systems and methods that enhance the understanding of molecular interactions.

Latest Patents

Feinberg's latest patents include groundbreaking work on "Systems and methods for spatial graph convolutions with applications to drug discovery and molecular simulation." This invention outlines a method for predicting characteristics of molecules through a series of graph convolutions based on molecular bonds and atomic distances. Another notable patent is focused on "Machine learning and molecular simulation based methods for enhancing binding and activity prediction." This method involves predicting relationships between ligands and receptors by analyzing various conformations and computing docking scores.

Career Highlights

Throughout his career, Feinberg has worked with esteemed institutions such as Leland Stanford Junior University and Memorial Sloan Kettering Cancer Center. His work has significantly impacted the fields of computational biology and drug design, showcasing his expertise and innovative thinking.

Collaborations

Feinberg has collaborated with notable colleagues, including Vijay S Pande and Bharath Ramsundar, further enhancing the scope and impact of his research.

Conclusion

Evan N Feinberg's contributions to innovation in molecular simulation and drug discovery highlight his role as a leading inventor in his field. His patents reflect a commitment to advancing scientific knowledge and improving methodologies in drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…